DIA492.21-0.79 -0.16%
SPY713.94+5.49 0.77%
QQQ663.88+12.46 1.91%

Adagio Medical ULTA technology featured in scientific sessions at Heart Rhythm 2026 conference

PUBT·04/16/2026 12:01:57
Listen to the news
Adagio Medical ULTA technology featured in scientific sessions at Heart Rhythm 2026 conference
  • Adagio Medical ULTA ventricular tachycardia ablation technology will be featured at Heart Rhythm 2026, held April 23-26, 2026 in Chicago.
  • Conference program includes multiple ULTA scientific presentations, including a late-breaking pivotal FULCRUM-VT trial session on April 26, 2026.
  • Adagio will run demonstrations at booth 1222 during Heart Rhythm 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adagio Medical Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202604160800BIZWIRE_USPR_____20260416_BW240050) on April 16, 2026, and is solely responsible for the information contained therein.

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.